Stephens Upgrades Neogenomics (NEO) to Overweight

Stephens analyst Mason Carrico upgraded Neogenomics (NASDAQ: NEO) from Equal Weight to Overweight with a price target of $18.00 (from $16.00).

For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.

Shares of Neogenomics closed at $13.55 yesterday.

You May Also Be Interested In

• Piper Sandler Upgrades Arthur J. Gallagher (AJG) to Overweight
• Guggenheim Upgrades Digital Realty Trust (DLR) to Buy
• Vermilion Energy (VET:CN) (VET) PT Lowered to Cdn$22 at RBC Capital